OvaScience Appoints Thomas Malley to Board of Directors

Published: Oct 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM, a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, announced the appointment of Thomas Malley to its Board of Directors.

“Tom’s knowledge of the healthcare industry and his expertise in identifying companies with breakthrough technologies will be invaluable to OvaScience as we seek to develop and commercialize new treatments for infertility,” said Michelle Dipp, M.D., Ph.D., Chief Executive Officer and Co-Founder of OvaScience.

Back to news